EUVIMED · CrossrefJournal
Journal of Medicinal Chemistry
ISSN 0022-2623 · American Chemical Society (ACS)
Latest articles
Ferrous Ion-Activatable Thiol-Selective Covalent-Reversible Electrophiles to Enhance Erastin-Induced Ferroptosis
Discovery of Pan-KRAS Inhibitor GNE-6226: Harnessing an Aminopyridine Pharmacophore to Broadly Target KRAS Mutants
Discovery and Clinical Development of Ceperognastat, a Low-Dose, CNS-Penetrant O -Linked N -Acetylglucosaminidase Inhibitor
Dual Inhibitors of Brain Carbonic Anhydrases and Cholinesterases Protect against Amyloid-β-Induced Neurotoxicity and Improve Cognitive Function in Mice
Discovery of First-in-Class hCA II/ROCK Dual Inhibitors with Both IOP-Lowering and Retinal Neuroprotective Activities for the Treatment of Glaucoma
Probing Different Chain Lengths and Saturation of the Fatty Acid Tail on Triglyceride-Mimetic Ionizable Lipids-Mediated siRNA Delivery
A Mitochondria-Targeted CPI-613 Derivative Overcomes Gemcitabine Resistance and Reduces Hepatic Metastasis in Pancreatic Cancer
Toward Consensus Definitions of Emerging Concepts in Medicinal Chemistry: A Community Call to Action
Correction to Discovery of DT-9081, a Potent and Orally Bioavailable Small Molecule Antagonist of the EP4 Receptor for the Treatment of Solid Cancers
Discovery of Potent and Selective Quinazoline-Based LATS1/2 Inhibitors Promoting Hepatic Regeneration
Development of Second Generation Thieno[2,3- d ]pyrimidin-4-one Derivatives as Positive Allosteric Modulators of the N -Methyl- d -Aspartate Receptor
Isotopic Labeling of the Tyrosine Kinase Inhibitor Binimetinib with Fluorine-18 and Preclinical Evaluation
What Does Generalizable AI in Drug Discovery Really Mean?
Toward Distributed Robustness in Resistance-Aware Lead Optimization
Discovery of an RNF126-Dependent Polθ Degrader Exhibiting In Vivo Activity in an HR-Deficient Tumor Model
Scaffold Hopping from Quinazoline to Tetrahydropyrido[3,4- d ]pyrimidine: Enhancing the Potency and Selectivity of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
Correction to: “Three Nitrogen Atoms Turn Old Kinase Inhibitors into New Targetable Remedy”
ATTEC-Based Autophagic Elimination of HBV Core Protein Achieves Potent Viral Suppression
Novel Spiroisatin Derivatives Potentially Useful for Preventing Myocardial Reperfusion Injury
Selective XPO1/CRM1 Inhibitor Verdinexor (KPT-335): The First and Only Oral Treatment Fully Approved by the U.S. FDA for Canine Lymphoma
Defining the Diphyllin Pharmacophore for Broad-Spectrum Antiviral V-ATPase Inhibition by Structure-Guided Scaffold Modifications
Discovery and Preclinical Characterization of Benzofuran Derivatives as Potent, Selective, and Orally Bioavailable GSPT1 Molecular Glue Degraders for the Treatment of MYC-Driven Cancers
Ubiquitination-Informed Reinforcement Learning Linker Generator Enables Discovery of Novel FGFR4 PROTAC Degraders
Engineering Camptothecin Prodrugs for Cancer Therapy: An Exposure-First Perspective
A Novel Mathematical Model for Predicting the Agonist Activity of Mixtures Containing Agonist and Antagonist Ligands in Drug Discovery Screening
Photoswitchable Inhibitors Targeting the Glucose Transporter GLUT1
Photoactivatable Small-Molecule PD-L1 Inhibitors for Checkpoint Blockade-based Tumor Immunotherapy
Lung-Tailored Pyrrolo-pyrimidine DDR Inhibitors Designed for Optimized Local Delivery
Cascade Mono- and Di-Functionalization of Anticancer Diastereomeric Benzoxazole-Ansamycins toward the Development of Highly Potent Hsp90 Inhibitors of Decreased Toxicity in Normal Cells
Alpha-Lipoic Acid Derivatives: A Multifunctional Neuroprotective Agent with Potential for Treating Ischemic Stroke
Volumes
2026 · 1,5092025 · 1,5672024 · 1,2862023 · 1,0292022 · 9752021 · 1,0682020 · 9732019 · 7722018 · 7972017 · 7562016 · 8372015 · 7592014 · 8362013 · 8232012 · 9252011 · 7412010 · 8182009 · 8712008 · 9272007 · 7672006 · 9242005 · 9322004 · 7812003 · 6502002 · 6662001 · 5332000 · 5761999 · 6081998 · 6341997 · 5721996 · 7371995 · 6211994 · 6121993 · 6031992 · 6851991 · 5211990 · 5331989 · 4361988 · 4141987 · 428
EUVIMED